Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

NCT00923130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Bevacizumab
DRUG: Ixabepilone

Sponsor

National Cancer Institute (NCI)